(A) Schematic of constructs and working principle.
(B) Representative images of CybSEP expression in differentiated PC12 cells when perfused with acidic and NH4Cl solutions, described in (C) (a, bath solution; b and c, acidic solution; d, NH4Cl; Scale bar, 100 μm).
(C) The traces of CybSEP and CybGam fluorescence change during application of various extracellular solutions.
(D) Quantification of percent ΔF/F0 peak intensity in CybSEP expressing PC12 cells (n= 9 over 3 experimental replicates; ***p < 0.001, ****p < 0.0001 via one-way ANOVA followed by Tukey’s multiple comparisons). BL indicates baseline.
(E and F) Average trace of fluorescence change during 70 mM KCl treatment and quantification of percent ΔF/F0 peak intensity in (E) (n=8–10 over 2 experimental replicates; **p < 0.01 via paired t test to the baseline).
(G and H) Average traces of fluorescence change during various electrical stimulation and quantification of percent ΔF/F0 peak intensity in (G). For extracellular calcium removal, 5 mM EGTA was used instead of CaCl2 (n=11–19, over 3 experimental replicates; **p < 0.001, ****p < 0.0001 via one-way ANOVA followed by Tukey’s multiple comparisons).
(I) Representative images of CybSEP2 with mCherry (mCh) or TetTox-mCh expressed in PC12 cells (Scale bar, 100 μm)
(J and K) Average traces of fluorescence change in CybSEP2 co-expressed with mCh or TetTox-mCh during electrical stimulation at 100 Hz and quantification of percent ΔF/F0 peak intensity in (J) (n=19–23, 3 over 3 experimental replicates; ***p < 0.0001 via two-way ANOVA followed by Šidák multiple comparisons). Data are represented as mean ± SEM.